Back to the main directory
EarningsReview / Equity
- Alfa Laval - Restoring confidence and flashing its quality by Danske Bank Equity Research
- Epiroc - Growing after-market provides stability by Danske Bank Equity Research
- Assa Abloy - Hold: Demand remains strong by Nordea
- Biotage - Buy/SEK 235 (220): PhyPrep is gaining traction by Nordea
- Finnair - Hold: A new strategy on the drawing board by Nordea
- Indutrade - Hold: Good stuff by Nordea
- Nimbus Group - Hold: Fairly calm waters overall by Nordea
- Swedbank - Buy/SEK 190 (185): Positive NII trend set to continue by Nordea
- Tele2 - Hold: Time to migrate by Nordea
- Terveystalo - Buy/EUR 13 (13.50): Supply constraints continued to hamper operations by Nordea
- Yara International - Buy/NOK 550: Volatility set to remain high by Nordea
- Carasent (Buy, TP: NOK45.00) - Positive signs in core markets by DnB Markets
- Ncc (Buy, TP: SEK155.00) - Q2 miss and increased uncertainty by DnB Markets
- Swedbank (Buy, TP: SEK188.00) - Benefiting from higher rates by DnB Markets
- Yara (Buy, TP: NOK550.00) - EU gas prices high, but so is EPS by DnB Markets
- Komplett (Buy, TP: NOK30.00) - Near-term softness looks priced in by DnB Markets
- Atlas Copco (Hold, TP: SEK110.00) - Estimates broadly unchanged by DnB Markets
- Axfood (Hold, TP: SEK305.00) - Ticking along by DnB Markets
- Swedish Match Minor model adjustments by DnB Markets
- Aberdeen Diversified Income and Growth Trust - Moving within the target by Edison Investment Research
- Norcros - Key strengths undervalued, legacy issues fixed by Edison Investment Research
- Telenor (TEL NO) by HSBC
- Some risk ahead, but path to $50 and beyond still clear by BNP Paribas Exane
- People on the move by BNP Paribas Exane
- (Inflation) crunch time by BNP Paribas Exane